Apriori Bio

Boston, United States

Apriori Bio offers a platform for creating variant-resilient vaccines and provides real-time insights to prepare for future outbreaks.

Jul 2024

Grant

Top Investors

Flagship PioneeringCoalition for Epidemic Preparedness Innovations

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Apriori Bio's investors?

Apriori Bio's investors include Flagship Pioneering, Coalition for Epidemic Preparedness Innovations.

Where is Apriori Bio headquartered?

Apriori Bio is headquartered in Boston, United States.

What does Apriori Bio do?

Apriori Bio offers a platform for creating variant-resilient vaccines and provides real-time insights to prepare for future outbreaks.

What stage is Apriori Bio at?

Apriori Bio is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 8, 2024.

MLA

"Apriori Bio — Funding & Investors." VCBacked, July 8, 2024, https://www.vcbacked.co/company/apriori-bio. Accessed July 1, 2026.

APA

VCBacked. (2024). Apriori Bio — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/apriori-bio

Wikipedia (cite web)

{{cite web |title=Apriori Bio — Funding & Investors |url=https://www.vcbacked.co/company/apriori-bio |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 8, 2024.